Michael A. Robinson- Money Morning - Only the News You Can Profit From.
Michael A. Robinson is a 34-year Silicon Valley veteran and one of the top technology financial analysts working today.
His work as a consultant, senior advisor and board member for Silicon Valley venture capital firms has placed him at the center of several major tech innovations including robotics used to revolutionize the auto industry... the $160 billion a year "Cloud Computing" industry... and the latest cyber military technologies.
He's also a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. It's no wonder that Silicon Valley defense publications vie for Michael's analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
His status as a leading tech analyst has garnered him rave reviews, too.
As editor of the financial newsletter American Wealth Underground, he amassed an amazing track record. The first analyst to uncover the rare earth mineral crisis, he amassed cumulative gains of 990% for his readers in just 16 months. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies - ones that have the power to sweep across the globe and change the very fabric of our lives - and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.com
Michael has an honors economics degree from the University of Missouri at Columbia. He's also a registered NRA Triple Distinguished Expert in shotgun, pistol, and rifle and one heck of a blues guitarist.
Michael'S LATEST HEADLINES
Technology Article 0 Wednesday, April 19, 2017Sometimes the Road to Wealth Is Paved by Tech – and Toothpaste
When it comes to biotech, so much vital R&D money goes down the drain.
Little wonder then that a major drug player might want to realign its operations to be less focused on the boom-and-bust cycle of drug research.
Today, we'll explore a Big Pharma leader that's doing just that.
It got started on this move three years ago.
It just made a big promotion that will serve as a further catalyst in this same direction.And its stock could make you 20% a year - or more - for a long time to come...
Technology Article 0 Monday, April 17, 2017When Putting Money on the Line, There's One Thing Worse Than "Fake News"
ETFs Article 2 Monday, April 10, 2017Two Huge Catalysts Are About to Reward Pot Stock Investors
Technology Article 0 Thursday, April 6, 2017Marijuana Millions' Northern Frontier Is Primed for Business
Technology Article 0 Tuesday, April 4, 2017We Can't Win Wars with Lasers, Yet – but We Can Double Our Money
Technology Article 0 Monday, April 3, 2017Apple Crosses the "$1,000" Mark – so It's Time for Another Prediction
Stocks 2Here's a Pure Play in a $25 Billion "Frontier" Market
trading strategies 11 Thursday, March 30, 2017Why I'm a Huge Fan of "Frontier Investing" in Pot Stocks
Technology Article 0 Tuesday, March 28, 2017If You Want to Double Your Money, Look Beyond the Price Tag
Technology Article 0 Friday, March 24, 2017To Make Big Money in Tech, You Have to Study the "Other Side" of Silicon Valley